1. Home
  2. RECT vs CTXR Comparison

RECT vs CTXR Comparison

Compare RECT & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rectitude Holdings Ltd

RECT

Rectitude Holdings Ltd

N/A

Current Price

$1.35

Market Cap

17.7M

Sector

N/A

ML Signal

N/A

Logo Citius Pharmaceuticals Inc.

CTXR

Citius Pharmaceuticals Inc.

N/A

Current Price

$0.54

Market Cap

18.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RECT
CTXR
Founded
1997
2007
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.7M
18.7M
IPO Year
2023
2010

Fundamental Metrics

Financial Performance
Metric
RECT
CTXR
Price
$1.35
$0.54
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.7K
★ 175.6K
Earning Date
07-30-2026
08-14-2026
Dividend Yield
★ 7.62%
N/A
EPS Growth
N/A
★ 43.38
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$104.18
P/E Ratio
$12.74
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.96
$0.47
52 Week High
$4.45
$2.19

Technical Indicators

Market Signals
Indicator
RECT
CTXR
Relative Strength Index (RSI) 51.11 48.00
Support Level $1.32 $0.55
Resistance Level $1.42 $0.61
Average True Range (ATR) 0.05 0.03
MACD -0.00 -0.00
Stochastic Oscillator 57.58 49.88

Price Performance

Historical Comparison
RECT
CTXR

About RECT Rectitude Holdings Ltd

Rectitude Holdings Ltd is principally involved in the provision of safety equipment, encompassing essential items such as personal protective clothing, hand gloves, safety footwear, and personal fall arrest systems (a system used to arrest an employee in a fall from a walking-working surface, usually consisting of a body harness, anchorage, and connector), portable fire extinguishers and traffic products such as rubber speed humps, wheel stops and wheel chocks. Additionally the company has added auxiliary products such as industrial hardware tools and electrical hardware required for construction sites.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products. It aims to provide therapeutic products that address unmet medical needs yet have a lower development risk than is usually associated with new chemical entities. The company's flagship product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein. It operates through a single operating and reportable segment which is focused on developing and commercializing pioneering targeted oncology therapies.

Share on Social Networks: